Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing

Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing

– Mekonos’ silicon nanoneedle-based delivery platform will provide Accelerated Bio with high efficiency, high viability cell engineering – including the precise and gentle delivery of multiplexed genetic cargo into its pluripotent hTSCs

– Accelerated Bio’s ethically derived and multi-functional hTSCs offer manufacturers a scalable and robust foundation for next-generation biomanufacturing 

– Using Mekonos’ technology, Accelerated Bio will bypass the limitations of conventional delivery approaches like electroporation, for improved non-viral delivery into its fragile stem cells

See more here

Comments are closed.